RESEARCH
Built on real‑world proof. Trusted in clinical practice.
Vara AI is backed by large‑scale studies, published research, and ongoing real‑world monitoring. From screening centres in Germany to global integrations, our solution supports radiologists and healthcare systems to detect breast cancer earlier and make more informed decisions.
PRAIM
Validated in the world’s largest prospective AI screening study
“The PRAIM study demonstrates that AI can safely be used as an independent reader in population-based breast cancer screening.”
100,000
100,000
Participants
↑1.0%
↑1.0%
Cancer
detection rate
↓1.0%
↓1.0%
Radiologist
workload
DECISION REFERRAL
Combining strengths of radiologists and AI
Decision referral is at the core of our AI concept. Here we explain what it is, how it works, and the impact it can have on radiologists' metrics when reporting with Vara.
MONITORING
Clinical safety does not end at validation.
Vara continuously monitors AI performance in real-world screening to ensure that clinically validated results remain stable, safe, and trustworthy after deployment—across sites, workflows, and evolving practice conditions.
